termination of pregnancy
Conditions
Interventions
Trade Name: Cytotec
Product Name: misoprostol
Pharmaceutical Form: Tablet
INN or Proposed INN: misoprostol
Concentration unit: µg microgram(s)
Concentration type: equal
Concentration number: 200-
Tra
Sponsors
Department of Health
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Women requesting and accepted for termination of pregnancy at less than 14 weeks gestation (as determined by ultrasound). Women under 16 years of age will be approached where they are determined to be Gillick competent (by the clinical practitioner) and where a parent/legal representative is present. Ability to give written informed consent. Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Pre-existing medical disorder which is an indication for either medical or surgical termination of pregnancy. Non-English speaking women (apart from French, Mandarin, Cantonese, Bengali, Urdu or Arabic) due to limited availability of Interpreters. Previous participation in this trial. Current participation in a 'drug' related trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: To determine the acceptibility of medical and surgical termination of pregnancy, as determined by the preferred method of any future termination ;Secondary Objective: To compare experiences of care, strength of preference, psychological impact, efficacy and cost effectiveness of surgical versus medical termination;Primary end point(s): The primary outcome variable is acceptibility of the method measured 2 weeks after the procedure; participants will be asked if they would have the same method of termination again. | — |
Countries
United Kingdom
Outcome results
None listed